Drug Type CpG ODN |
Synonyms- |
Target |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | - | |
Bladder Cancer | Discovery | US | - | |
Colonic Cancer | Discovery | US | - | |
Diffuse Large B-Cell Lymphoma | Discovery | US | - | |
Follicular Lymphoma | Discovery | US | - | |
Head and Neck Neoplasms | Discovery | US | - | |
Leukemia | Discovery | US | - | |
Mantle-Cell Lymphoma | Discovery | US | - | |
Marginal Zone B-Cell Lymphoma | Discovery | US | - | |
Melanoma | Discovery | US | - |